top of page

PDE6B

Disease Category: autosomal recessive

Patient Population: unknown

Active Clinical Trials: None currently active

Treatment Options: 

Strategies to Preserve Eye Health: Lutein

Institution(s) Conducting Research: Jules Stein Eye Institute, UPMC Scheie Eye Institute, Clinique Ophtalmologique, Quinze-Vingts (XV-XX) National Ophthalmology Hospital

FACES OF RP

IMG_5742_edited.jpg

Lemay-Pelletier kids
Quebec, Canada

BRIEF SUMMARY

PDE6B retinitis pigmentosa is a rare, inherited eye disease that causes vision loss. It's caused by mutations in the PDE6B gene, which encodes the beta subunit of rod cGMP phosphodiesterase, which regulates signal transduction. It is a progressive and irreversible disease. PDE6B retinitis pigmentosa is inherited in an autosomal recessive pattern. It is estimated that up to 5% of ar-RP cases are caused by mutations in PDE6B gene which encodes the beta subunit.

 

Symptoms include night blindness that appears early, visual field defects that worsen over time, and central vision loss. Vision loss becomes more noticeable as the disease worsens. Most patients never completely lose their vision

 

At this time, there is no effective treatment for PDE6B retinitis pigmentosa. Adeno-associated virus (AAV)-mediated gene therapy is a promising strategy.​

​

This is for informational purposes only. For medical advice or diagnosis, consult a professional. 

IN THE NEWS

bottom of page